This is a preview of subscription content, log in via an institution to check access.
References
Carrey NJ, Wiggins DM, Milin RP. Pharmacological treatment of psychiatric disorders in children and adolescents. Focus on guidelines for the primary care practitioner. Drugs 1996 May; 51(5): 750–759
Attention deficit hyperactivity disorder most likely to respond to psychostimulants. Drug Ther Perspect 1994; 3 (2): 8–12
Kaplan CA, Hussain S. Use of drugs in child and adolescent psychiatry. Br J Psychiatry 1995; 166: 291–8
Remschmidt H, Schulz E, Herpertz-Dahlmann B. Schizophrenic psychoses in childhood and adolescence. A guide to diagnosis and drug choice. CNS Drugs 1996 Aug; 6(2): 100–12
Hazell P. Tricyclic antidepressants in children. Is there a rationale for use? CNS Drugs 1996 Apr; 5(4): 233–9
Riddle MA, Scahill L, King RA, et al. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1992; 31: 1062–9
King RA, Riddle MA, Chapell PB, et al. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 1991; 30: 179–86
Rights and permissions
About this article
Cite this article
Pharmacotherapy facilitates management of psychiatric disorders in children and adolescents. Drugs Ther. Perspect 8, 9–12 (1996). https://doi.org/10.2165/00042310-199608070-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199608070-00003